The Financial Potential of Convertible Notes in the Pharmaceutical Sector

Jun 26, 2024

In the realm of biotech and pharmaceuticals, fundraising often plays a pivotal role in driving innovation and progress. Biotech and pharmaceutical companies, whether private startups or established public firms, frequently turn to convertible notes as a strategic financial instrument.

In this MedCity News article, WM Valuation Managing Director, Jaylon Reynolds, shares his perspective on convertible notes as a flexible financing solution for companies awaiting future rounds of funding.

Read more here